Tuesday, 27 October 2026European Markets

VEIDEKKE, VAN DE VELDE, Another 2 Companies Have A High Estimated Dividend Yield

Loading stream...

(vianews) - veidekke (vei.ol), van de velde (van.br), ca toulouse 31 cci (cat31.pa) have the highest dividend yield stocks on this list.

financial asset forward dividend yield updated (est)
veidekke (vei.ol) 6.97% 2023-04-16 07:32:14
van de velde (van.br) 5.72% 2023-04-16 11:17:07
ca toulouse 31 cci (cat31.pa) 4.78% 2023-04-16 11:45:44
catana group (catg.pa) 2.09% 2023-04-16 11:46:00

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. veidekke (vei.ol)

6.97% foward dividend yield

veidekke's last close was kr115.60, 10.25% below its 52-week high of kr128.80. intraday change was 1.22%.

veidekke asa operates as a construction and property development company. it operates through construction norway, infrastructure norway, construction sweden, infrastructure sweden, and denmark/hoffmann segments. the company operates as a construction contractor; executes civil engineering and renovation projects; and produces asphalt and aggregates, as well as operates in the public road maintenance market. it is also involved in the civil engineering, recycling, and asphalting projects, as well as constructs commercial and residential buildings. veidekke asa was founded in 1936 and is headquartered in oslo, norway.

earnings per share

as for profitability, veidekke has a trailing twelve months eps of kr8.23.

pe ratio

veidekke has a trailing twelve months price to earnings ratio of 14.09. meaning, the purchaser of the share is investing kr14.09 for every norwegian krone of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 39.56%.

yearly top and bottom value

veidekke's stock is valued at kr116.00 at 02:50 est, below its 52-week high of kr128.80 and way higher than its 52-week low of kr80.90.

revenue growth

year-on-year quarterly revenue growth grew by 6.5%, now sitting on 38.66b for the twelve trailing months.

more news about veidekke.

2. van de velde (van.br)

5.72% foward dividend yield

van de velde's last close was €36.15, 9.06% under its 52-week high of €39.75. intraday change was 0.14%.

van de velde nv, together with its subsidiaries, designs, develops, manufactures, and markets fashionable luxury lingerie and swimwear for women worldwide. it operates through two segments, business to business (b2b) and direct to consumer (d2c). the company offers its products under the primadonna, marie jo, andres sarda, and lingerie styling brands. it also operates retail websites; stores; and boutiques and department stores. the company was founded in 1919 and is headquartered in schellebelle, belgium. van de velde nv is a subsidiary of van de velde holding nv.

earnings per share

as for profitability, van de velde has a trailing twelve months eps of €2.86.

pe ratio

van de velde has a trailing twelve months price to earnings ratio of 12.66. meaning, the purchaser of the share is investing €12.66 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 22.23%.

yearly top and bottom value

van de velde's stock is valued at €36.20 at 02:50 est, under its 52-week high of €39.75 and way higher than its 52-week low of €29.45.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, van de velde's stock is considered to be oversold (<=20).

more news about van de velde.

3. ca toulouse 31 cci (cat31.pa)

4.78% foward dividend yield

ca toulouse 31 cci's last close was €69.41, 12.69% under its 52-week high of €79.50. intraday change was 1.27%.

caisse regionale de credit agricole mutuel toulouse 31 operates as a cooperative bank in france. it offers bank accounts and card; savings products, including real estate investments, stock exchanges and financial investments, and retirement savings solutions; and real estate loans, and consumer credit facilities. the company also provides life, car and two-wheeler, home, personal, leisure and daily life, and borrower insurance products. caisse regionale de credit agricole mutuel toulouse 31 was incorporated in 1992 and is based in toulouse, france.

earnings per share

as for profitability, ca toulouse 31 cci has a trailing twelve months eps of €14.7.

pe ratio

ca toulouse 31 cci has a trailing twelve months price to earnings ratio of 4.76. meaning, the purchaser of the share is investing €4.76 for every euro of annual earnings.

more news about ca toulouse 31 cci.

4. catana group (catg.pa)

2.09% foward dividend yield

catana group's last close was €7.18, 18.87% below its 52-week high of €8.85. intraday change was 0.83%.

sa catana group manufactures and sells pleasure boats, sails, and motors in france and internationally. it also offers boat work, garage rentals, guarding, and berth services. the company markets its products under the catana, bali, and catspace brands. sa catana group was founded in 2001 and is headquartered in canet-en-roussillon, france.

earnings per share

as for profitability, catana group has a trailing twelve months eps of €0.55.

pe ratio

catana group has a trailing twelve months price to earnings ratio of 13.2. meaning, the purchaser of the share is investing €13.2 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 29.84%.

yearly top and bottom value

catana group's stock is valued at €7.26 at 02:50 est, way below its 52-week high of €8.85 and way higher than its 52-week low of €4.61.

more news about catana group.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Window: ESMO Data, the Ivonescimab PDUFA and Small-Cap Delistings
Mid-October to November 2026 is a dense catalyst period for clinical-stage biotech. Positive late-stage readouts (ALOFT-IPF, TELIGAN, MIUDELLA, the duvakitug extension) and the ESMO 2026 presentations lead up to the FDA's 14 November PDUFA date for the ivonescimab BLA. At the opposite end of the market, Spago Nanomedical is moving to delist from Nasdaq First North, which shows how hard it is for micro-cap developers to fund themselves. Value is concentrating in companies with late-stage data and near-term regulatory outcomes.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,500 source documents archived
Query this data → isubstrate.com